+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis



In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis



Antimicrobial Agents and ChemoTherapy 55(10): 4755-4764



Carbaporphyrin ketals are porphyrinoid compounds in which a pyrrole ring of a typical porphyrin macrocycle has been replaced by a ketal-substituted indene ring. It was recently demonstrated that these compounds are effective in vitro against Leishmania tarentolae. Their in vitro effectiveness is increased when they are exposed to visible light; they act as photosensitizers capable of mediating the production of reactive oxygen species (ROS). Following on this evidence, the effectiveness and cytotoxicity of the dimethyl and diethyl carbaporphyrin ketals (CKOMe and CKOEt, respectively) were determined in vitro using pathogenic Leishmania species with and without exposure to visible light (2 and 4 h). The effectiveness against various pathogenic Leishmania species was determined to be in a micromolar range. Additionally, the effect of encapsulating the carbaporphyrin ketals in liposome formulations was tested. Liposomal delivery diminished their toxicity, while the effectiveness was enhanced upon exposure to visible light (photodynamic effect). The cytotoxicity levels for human U937 cells and hamster peritoneal macrophages were in the ranges of 0.3 to 9 μM and 7 to 330 μM, respectively. When tested in vivo, using a hamster (Mesocricetus auratus) model of cutaneous leishmaniasis, CKOMe was active even in the dark, suggesting that the compound, once metabolized in the animal tissue, produces an active ingredient that does not seem to be photosensitive. Reduction in lesion size, histopathologic analyses, and smears confirmed the in vivo effectiveness of the compound, since the parasitic load was diminished without noticeable toxic effects.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036203855

Download citation: RISBibTeXText

PMID: 21788471

DOI: 10.1128/aac.00671-11


Related references

Carbaporphyrin ketals as potential agents for a new photodynamic therapy treatment of leishmaniasis. Bioorganic and Medicinal Chemistry 16(14): 7033-7038, 2008

Topical treatment of cutaneous leishmaniasis in Belize: in vitro and in vivo studies with Leishmania mexicana. International Journal for Parasitology 23(1): 121-127, 1993

In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis. Journal of Pharmacy and Pharmacology 58(8): 1043-1054, 2006

Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies. Antimicrobial Agents and ChemoTherapy 59(9): 5804-5813, 2015

A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis. Plos Neglected Tropical Diseases 9(9): E0003889, 2015

Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis. Plos Neglected Tropical Diseases 6(11): E1927, 2012

The potential utility of green tea extract as a novel treatment for cutaneous leishmaniasis. Journal of Alternative and Complementary Medicine 15(8): 815-816, 2009

Amphotericin B-loaded nanocarriers for topical treatment of cutaneous leishmaniasis: development, characterization, and in vitro skin permeation studies. Journal of Biomedical Nanotechnology 8(2): 322-329, 2012

In vitro and in vivo efficacy of novel flavonoid dimers against cutaneous leishmaniasis. Antimicrobial Agents and ChemoTherapy 58(6): 3379-3388, 2014

Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies. Drug Design Development and Therapy 8: 1235-1247, 2014

Studies on cutaneous leishmaniasis in India. III. Detection of a zoonotic focus of cutaneous leishmaniasis in Rajasthan. Journal of Communicable Diseases 5(3): 149-153, 1973

Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis. Journal of Antimicrobial ChemoTherapy 64(1): 84-87, 2009

In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis. Plos Neglected Tropical Diseases 8(7): E2999, 2014

Triphenylmethane derivatives have high in vitro and in vivo activity against the main causative agents of cutaneous leishmaniasis. Plos one 8(1): E51864, 2013

FAO specifications for plant protection products. Demeton, a mixture of diethyl 2-(ethylthio)ethyl phosphorothionate and diethyl S-(2-(ethylthio)ethyl) phosphorothiolate, demeton-S-methyl, S-(2-(ethylthio)ethyl)dimethyl S-(2-(ethylthio)ethyl)dimethyl diethyl S-(2-(ethylthio)ethyl) thiometon, S-(2(ethylthio)ethyl)dimethyl phosphorothiolothionate. FAO specifications for plant protection products Demeton, a mixture of diethyl 2 ethylthioethyl phosphorothionate and diethyl S 2 ethylthioethyl phosphorothiolate, demeton S methyl, S 2 ethylthioethyldimethyl S 2 ethylthioethyldimethyl diethyl S 2 ethylthioethyl thiometon, S 2ethylthioethyldimethyl phosphorothiolothionate: 27, 1973